| Byetta (exenatide) / AstraZeneca |
NCT00923715: Exenatide (Byetta) Versus Pramlintide (Symlin): Role in Post-Prandial Hyperglycemia |
|
|
| Enrolling by invitation | 3 | 63 | US | Insulin, Insulin and Exenatide, Insulin and Pramlintide | Baylor College of Medicine, Albert Einstein College of Medicine of Yeshiva University | Diabetes Mellitus, Type 1 | 12/11 | 05/12 | | |
ChiCTR-IPR-15006558: A randomized, double-blinded, postive-controlled, multicentered, 16-week study, assessing the effecacy and safeness of exenatide in type 2 diabetes with metformin/secretagogues alone or both |
|
|
| Completed | 3 | 240 | | exenatide ;Byetta | Peking University Third Hospital; Level of the institution：, Qinghai Chenfei Pharmaceutical Corparation, LTD | Type 2 diabetes mellitus | | | | |
2013-004755-21: Assessing efficacy and safety of exenatide in the treatment of hypothalamic obesity Evaluer l’efficacité et la tolérance du traitement par exénatide dans l’obésité hypothalamique. |
|
|
| Ongoing | 3 | 50 | Europe | Solution for injection in pre-filled pen, BYETTA | CHU de Bordeaux, Ministry of Health | Hypothalamic obesity after craniopharyngioma therapy. Obésité hypothalamique de l’adulte secondaire au traitement du craniopharyngiome., Hypothalamic obesity. Obésité hypothalamique, Body processes [G] - Metabolic Phenomena [G03] | | | | |
NCT00679042: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol |
|
|
| Active, not recruiting | 3 | 21 | US | Islets of Langerhans transplantation, Islets of Langerhan (Islets), Basiliximab (Simulect®), Tacrolimus (Prograf®), Sirolimus (Rapamune®), Etanercept(Enbrel®), Exenatide (Byetta®) | CellTrans Inc. | Type 1 Diabetes Mellitus | 07/17 | 06/26 | | |
| Not yet recruiting | 3 | 270 | RoW | Exendin-4 Fc fusion protein injection, JY09(1.2mg), JY09(2.4mg), Placebo, Injection mimetic | Beijing Dongfang Biotech Co., Ltd. | Type 2 Diabetes Mellitus | 04/25 | 12/25 | | |
DFBT-JY09-DM-302, NCT06257966: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin |
|
|
| Not yet recruiting | 3 | 600 | RoW | Exendin-4 Fc fusion protein injection(1.2mg）, JY09(1.2mg), Exendin-4 Fc fusion protein injection（2.4mg）, JY09(2.4mg), Dulaglutide, Metformin | Beijing Dongfang Biotech Co., Ltd. | Type2 Diabetes Mellitus | 04/25 | 12/25 | | |
| Completed | 2/3 | 92 | US | Byetta 5Mcg Pen Injection, Exenatide | University of Colorado, Denver, National Center for Advancing Translational Sciences (NCATS), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Hepatic Steatosis, Polycystic Ovarian Syndrome, Obesity | 12/22 | 12/22 | | |
